Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure. (Q38092812)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Mei-shu Lai

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

5

Jou-Wei Lin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

2

Yen-Chieh Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

4

Min-Shung Lin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Yu-Heng Chung

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

Pharmacoepidemiology and Drug Safety

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

583-592

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.

27 February 2020

cites work

1 reference

Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evalu

21 January 2018

1 reference

Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events

21 January 2018

1 reference

Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease.

21 January 2018

1 reference

Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics

21 January 2018

1 reference

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

21 January 2018

1 reference

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

21 January 2018

1 reference

Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease

21 January 2018

1 reference

Effects of pitavastatin (LIVALO tablet) on the estimated glomerular filtration rate (eGFR) in hypercholesterolemic patients with chronic kidney disease. Sub-analysis of the LIVALO Effectiveness and Safety (LIVES) Study

21 January 2018

1 reference

New evidence on pitavastatin: efficacy and safety in clinical studies

21 January 2018

1 reference

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the progression of renal dysfunction in Japanese hypertensive patients

21 January 2018

1 reference

Pravastatin and cardiovascular risk in moderate chronic kidney disease.

21 January 2018

1 reference

Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients

21 January 2018

1 reference

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

21 January 2018

1 reference

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

21 January 2018

1 reference

No evidence for statin-induced proteinuria in healthy volunteers as assessed by proteomic analysis

21 January 2018

1 reference

Meta-analysis: the effect of statins on albuminuria

21 January 2018

1 reference

Dose-dependent effect of rosuvastatin treatment on urinary protein excretion.

21 January 2018

1 reference

Pitavastatin: evidence for its place in treatment of hypercholesterolemia

21 January 2018

1 reference

A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity.

21 January 2018

1 reference

An application of propensity score matching using claims data

21 January 2018

1 reference

Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding

21 January 2018

1 reference

Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.

21 January 2018

1 reference

How to prevent progression to end stage renal disease.

21 January 2018

1 reference

Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease

21 January 2018

1 reference

Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway.

21 January 2018

1 reference

Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).

21 January 2018

1 reference

Dyslipidemia in chronic kidney disease: managing a high-risk combination

21 January 2018

1 reference

Public health impact of statin prescribing strategies based on JUPITER.

21 January 2018

1 reference

Do HMG-CoA reductase inhibitors improve kidney function? The saga continues

21 January 2018

1 reference

Epidemiology, impact and preventive care of chronic kidney disease in Taiwan

21 January 2018

1 reference

Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study

21 January 2018

1 reference

Comparison of clinical outcomes of hydrophilic and lipophilic statins in patients with acute myocardial infarction

21 January 2018

1 reference

The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PDS.3433

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526815%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference